This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Geza de Takats, MD
Rush-Presbyterian-St. Luke's Medical Center Chicago

JAMA. 1974;227(10):1121.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Dr. Richard Sautter accuses my recent editorial of a misinterpretation of the findings of a cooperative trial organized to evaluate the thrombolytic activity of urokinase in pulmonary embolism.

The report did yield valuable data, and the immense amount of detailed work is admirable. What the editorial objected to can be summed up under two headings. First, thrombolytic agents such as streptokinase and urokinase have long been known to dissolve fresh clots in the vascular system. Dr. Sautter and his associates have notably contributed to this subject, having shown quite recently that the response of the fibrinolytic system to surgical stress varies from patient to patient, a subject in which my associates and I have been involved for a long time. Obviously, the defensive mechanisms of the body depend on many factors, and defective thrombolysis may well be an important factor in the formation and lysis of thromboemboli . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?